How this is made
Talleyrand reads the Medicare Advantage record every week — filings, earnings calls, CMS files, the Federal Register, trade press — and publishes the small share of it that changed something. Last week that was fourteen items out of six hundred and twenty-five.
The filtering is the product. This page explains how it works, what it refuses to do, and where a person overrides a machine.
Where the numbers come from
Every figure published here traces to a document anyone can open: company filings and 8-K exhibits, earnings call transcripts, the CMS monthly enrolment and contract files, the Federal Register, CMS rate announcements and final rules, and named trade press.
Nothing is published from private knowledge, briefings or conversations. That is not a promise about intent — it is a property of how the pipeline is built. A figure that cannot be tied back to a source document does not reach the page, because the check that would let it through does not exist.
Where a number is reported by someone else rather than filed, it says so and credits the publication that did the work. Where a company figure and a CMS file disagree, both appear.
Every figure names its book
Medicare Advantage, Medicaid, Commercial and Exchange behave differently and are routinely blurred together in coverage. Here they are not. A membership or margin figure states which book it describes, and where a non-MA figure is used to make a point about MA it is labelled as a read-across rather than presented as evidence.
What the pipeline refuses to publish
Most publications describe their standards. This one enforces them in code — checks that run on every edition before anything is written. Copy that fails does not publish until it is removed or rewritten.
- A figure with no source. Every number carries provenance or it is dropped.
- A quotation that does not match the transcript. Management quotes are checked verbatim against the annotated call.
- A figure whose period is unclear. A quarter compared to the wrong quarter is a wrong number.
- A dead or wrapped link. A source you cannot open is not a source.
- A segment figure that does not name its book. See above.
- Anything that reads as Talleyrand investment advice. Talleyrand does not produce a recommendation, valuation conclusion or price view. A named analyst's dated rating or target action may be reported as a sourced fact, never endorsed or converted into upside or downside.
- Any Talleyrand interpretation of a named payer. The rule, below.
What is written by a machine, and what is decided by a person
Tally is the name for the automated part of this. It is not a person, it is not a byline in the ordinary sense, and pretending otherwise would undermine the point of the page you are reading.
Tally does
- Reads the week's record — hundreds of items — and scores what moved
- Drafts the summaries and the week's argument
- Reconciles every figure against the filing it came from
- Builds the enrolment pages from CMS files, with no model-written prose where it touches a named payer
- Runs the checks above and refuses what fails
A person does
- Sets what counts as significant, and revises it when it is wrong
- Decides what publishes and what is held
- Writes the standing rules the drafting works from
- Owns every correction
- Answers the replies
The division matters because the failure modes differ. A machine is consistent and can be confidently wrong. A person is inconsistent and notices when something smells off. The checks exist to catch the first; the second is why anything is held back at all.
One rule for every payer
Disclosure
The author of Talleyrand is employed by Humana. Talleyrand is a personal project, written on personal time and personal equipment. It is not affiliated with, endorsed by, funded by or produced for Humana or any other company, and nothing here represents the views of any employer.
That fact is a reason to disclose the relationship, not a reason to treat one payer differently. The rule is the same for every company covered here:
The rule
Every payer covered here appears through sourced facts and attributed voices, never a Talleyrand opinion. Its filed figures, enrolment, dated events and management's own words are reported like anyone else's. Talleyrand offers no assessment, inference or characterisation of a payer's performance, strategy, prospects or decisions.
A named external analyst's view may appear only as theirs: an exact quotation or an exact public rating or target action, with the speaker or firm, date and source link visible. An action-only item is separated from the explanatory summary and marked as unexplained; it cannot answer why the analyst changed a target. A research desk or media outlet's explanatory language or concise high-signal takeaway may also appear, visibly labelled as a media takeaway and quoted exactly. Research continues beyond the first qualifying sentence. A separate automated pass revisits recent earnings coverage over a finite 21-day window, seeking three explanatory takeaways across two public sources when available. The page selects up to three distinct takeaways, consolidates syndicated duplicates and stops after four passes rather than crawling indefinitely. These are reporting, not endorsement. Talleyrand does not paraphrase either into a house conclusion, calculate an implied return, or use an older rationale to explain a newer action unless the newer source makes that connection itself.
Where a payer development is part of something happening across the market, it is named as part of that pattern and the interpretation stays at the level of the pattern.
This is enforced the same way everything else here is. A check refuses issuer-level analysis and any payer sentence that carries Talleyrand judgement rather than trusting anyone to remember. Each payer's earnings page carries filed numbers, sourced factual takeaways, guidance language as written, the annotated call and clearly attributed external views — and no Talleyrand read. You should be able to distinguish every fact from every source's opinion and find nothing that tells you what Talleyrand thinks about that company.
The asymmetry is not between companies. It is between the record and the market: the record names what each payer did; the interpretation belongs to a pattern that the evidence can support.
What this is not
It is not investment advice, and nothing here is a recommendation to buy or sell anything. Talleyrand covers publicly traded companies because that is where the disclosure is, not because it has a view on their securities. It may report that a named analyst issued a rating or changed a target; that is a fact about analyst coverage, not a recommendation by Talleyrand. If unquoted Talleyrand copy anywhere on this site reads like a trading idea, it is a defect — tell me and it will be removed.
It is not legal, regulatory, actuarial or compliance advice. It is not a substitute for reading the filing, and every page links to the filing so you can.
Corrections
This publication makes quantitative claims about named companies every week, some of them drafted by a machine. It will be wrong sometimes. When it is:
- The correction is made on the page where the error appeared, and the page says what changed and when.
- Material errors are named in the following edition rather than quietly patched.
- The archive is not rewritten to look better than it was. A corrected page shows that it was corrected.
- Corrections are welcome from anyone, including from companies covered here, and they are handled the same way whoever sends them.
The fastest way to get something fixed is to send the sentence and the source.
Getting in touch
Replies come to a person, usually the same day. Corrections especially.
tally@talleyrandintelligence.com